Entropy Technologies’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Entropy Technologies's LGND Position: Q3 2026 in Review
Entropy Technologies opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 9,931 shares worth $3.1M. The stake represents 0.1% of the portfolio and ranks #281 among its holdings.
432 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Entropy Technologies held 9,931 shares of Ligand Pharmaceuticals worth $3.1M as of Q3 2026.
- Ligand Pharmaceuticals was a new Entropy Technologies position in Q3 2026.
- Ligand Pharmaceuticals made up 0.1% of Entropy Technologies's portfolio in Q3 2026, its #281 holding.
- 432 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.